Breaking News, Financial News

Financial Report: Kendle 3Q10

Early Stage revenues were $6.3 million (-4%). Late Stage revenues were $76.2 million (-17%).

Kendle 3Q10

3Q Revenues: $112.6 million (-16%)

3Q Earnings: $1.5 million (earnings were $8.8 million in 3Q09)

YTD Revenues: $340.4 million (-19%)

YTD Earnings: $4.6 million (earnings were $12.9 million YTD10)

Comments: Early Stage revenues were $6.3 million (-4%). Late Stage revenues were $76.2 million (-17%). Contract cancellations and related adjustments in the quarter totaled $10.4 million. Backlog at Sept. 30th totaled $807.4 million (+4%). Service revenues in the quarter totaled $83.2 million (-20%).

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters